Plasminogen activator inhibitor 1--insulin-like growth factor binding protein 3 cascade regulates stress-induced senescence.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 22778398.
- Also identified by DOI 10.1073/pnas.1120437109 and PMC identifier 3409757.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cellular senescence is widely believed to play a key role in tumor suppression, but the molecular pathways that regulate senescence are only incompletely understood. By using a secretome proteomics approach, we identified insulin-like growth factor binding protein 3 (IGFBP3) as a secreted mediator of breast cancer senescence upon chemotherapeutic drug treatment. The senescence-inducing activity of IGFBP3 is inhibited by tissue-type plasminogen activator-mediated proteolysis, which is counteracted by plasminogen activator inhibitor 1 (PAI-1), another secreted mediator of senescence. We demonstrate that IGFBP3 is a critical downstream target of PAI-1-induced senescence. These results suggest a role for an extracellular cascade of secreted proteins in the regulation of cellular senescence.
Medical subject headings
- Cellular Senescence
- Insulin-Like Growth Factor Binding Protein 3
- Neoplasms
- Plasminogen Activator Inhibitor 1
- Proteolysis
- Stress, Physiological
- Tissue Plasminogen Activator